Ginsenoside Re inhibits melanoma development by downregulating ERK and reduces EMT in non-small cell lung cancer cells by interfering with M2-like macrophage polarization (Hwang et al., 2023; Tang et al., 2024). Here, MAPK1 is linked to melanoma.